| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.08B | +9.6% |
| Gross profit | ¥0.02B | — |
| Operating income | ¥-0.00B | — |
| Net income | ¥-0.00B | -257.4% |
| Gross margin | 22.5% | Net margin -4.3% |
| Revenue Q/Q | -15.8% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.06B | 77.5% |
| R&D | ¥0.00B | 1.7% |
| SG&A | ¥0.01B | 17.4% |
| Tax & other | ¥-0.00B | -0.4% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
屹通新材 ・ 通用电梯 ・ 三友联众 ・ 中辰股份 ・ 盈建科 ・ 中英科技 ・ 药易购 ・ 信测标准 ・ 秋田微 ・ 南极光 ・ 创识科技 ・ 易瑞生物
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies